Allosteric inhibitors work by inducing a conformational change in the enzyme structure. When the inhibitor binds to the allosteric site, it alters the shape of the enzyme, including the active site. This change can either reduce the enzyme's affinity for the substrate or render the active site less effective in catalyzing the reaction. This mechanism allows for fine-tuned control over enzyme activity, often essential in metabolic pathways.
